EUROPEAN TERATOLOGY SOCIETY (E.T.S.)

European Teratology Society

Dedicated to the Prevention of Adverse Effects on Reproduction and Development

The objectives of the Society are to stimulate interest in and promote the exchange of ideas and information about the etiology, prevention and treatment of congenital malformations


ETS COUNCIL NEWS

Please click on the button below for the latest ETS News and Information

Last updated 1 May 2008

 


 

ETS Members Only:

If you have forgotten your password DO NOT RE-REGISTER, use the Forgotten Username/Password button

Unless you have registered electronically (Membership status verified) and have been e-mailed a password you will not be able to access the ETS Members Area

Members: Click SEND to email your current contact details to the ETS Secretary

 

COUNCIL AREA

(password protected)

access is also possible from Members Area

European Teratology Society

 

  • This is a separate Secure area within the ETS Members site to allow the Council to access specific documents and carry out any confidential business

 

MEMBERS AREA (password protected)

click logo to access or on underlined links opposite

  European Teratology Society

 

 NON-MEMBERS

click logo to access

European Teratology Society

 

If you wish to apply for membership to the ETS please complete an application form.

Non Members requesting access using the Electronic Registration Form will not be taken into consideration for access and will not be contacted

 


 

New Version of Terminology in Developmental Toxicology

 

A new draft version of the DevTox Terminology is now available and open for comments. This draft version was developed in close cooperation between ETS, Teratology Society, and Japanese Teratology Society and took into account a significant European input. All interested persons are invited to comment on this draft version.

The deadline for comments has now closed, however if you still wish to comment please contact Jochen Buschmann.

 

The observations in the glossary are organized into four tables for external, visceral and skeletal abnormalities. A new table was included containing maternal-fetal abnormalities. The basis for inclusion of observations listed within each of these tables is 'type of abnormality' and the three tables are mutually exclusive (ie no abnormality is included in more than one table).  However, it is expected that, in practice, abnormalities from any of the three tables might be selected for inclusion within internal glossary tables, set up for particular 'examination types' within a particular laboratory, and some observations might be included in more than one table.

In addition to the tables, the new version includes five appendices:

APPENDIX A:             Descriptive Terminology Used More Than Once in the Glossary

APPENDIX B:             Syndromes and Combining Terms

APPENDIX C:             Nomenclature – alternative terms

APPENDIX D:             Structural differences – rat, mouse and rabbit

APPENDIX E:             Observation terms that are not synonymous

External Draft

Maternofetal draft

Skeletal draft

Visceral draft

 


RASS XIII

The Thirteenth Risk Assessment Summer School

to be held September 6 - 14, 2008

Hotel Hoeri, Bodensee, Germany

 

More about RASS: http://www.iutox.org


 

 

ETS 2008 CONFERENCE

 

36th Annual Conference of the European Teratology Society

 

This special joint meeting of ETS and ESTP will be organised jointly with European Network of Teratology Information Services (ENTIS) and the British Society of Toxicological Pathologists (BSTP) and will take place in Edinburgh, Scotland, from


September 21 – 26, 2008
 

 

 

 

 

 

 

 

 

 

 

ETS in EDINBURGH 2008 :  Call for Abstracts
Participants interested in giving an oral or poster presentation are invited to submit an abstract.  You are especially encouraged to send in work on topics related to the main symposia (epidemiological biomarkers of exposure, cardiovascular defects, juvenile toxicity, sex organ development and endocrine disruption) which can be given as free communications.
The maximum size of posters is 1000 mm wide x 2000 mm high

Abstract template:

Abstract title:  In bold capitals
Authors names in bold, with full first name and second initial, and presenting author with asterisk after surname.
Affiliation in italics, name of institute, place and country only.  With more than one affiliations indicate by superscript numbers and match with superscript numbers after surnames.
One line spacing before body text
Abstract body in plain text in one paragraph, no indents or empty lines. 
No figures or tables, up to three references acceptable.  Organize text in: introduction, methods, results and conclusions.  Provide factual text.  Avoid general statements like: 'results will be presented'.
Use 300 up to a maximum of 500 words for complete abstract text (including title, authors, affiliation and body text).  Title: In bold capitals..
Add preference choice for poster or oral presentation.
Abstract deadline : 1 April 2008

Please email abstracts to :  secretary@etsoc.com

 

 

 

 

 


 

Paediatric Toxicology

 The Modular Training Programme in Applied Toxicology is a broad and flexible programme for continuing education in all aspects of chemical safety.

Why a module on Paediatric Toxicology?  Children’s health has received much attention by regulators, the scientific community and the public. This is not surprising as many drugs used to treat children have never been formally tested in paediatric clinical trials and are used “off label” at dose levels derived by adjustment from adult dose levels. Children are also a vulnerable group for environmental chemicals since they may display novel toxicities not observed in adults or may be more or less sensitive to known toxicities. There are a significant number of examples where drugs have produced markedly different results in the small child in comparison with adults, even when administered at similar mg/kg dose levels. Differences in toxicity findings between children and adults can often be explained by differences in drug metabolism and pharmaco/toxicokinetics or by potential effects on those organ systems which are still developing post-nataly.  

 To date, drugs for use in children have not undergone such extensive safety testing in young animals - tests which may predict potential issues in man.  Standard animal tests in the reproductive portfolio end with the pre- and post-natal test where the offspring are exposed via the milk to about Day 21 of age, whilst the general toxicology portfolio opens at puberty at 6 weeks of age.
To bridge this gap a whole new set of guidelines is being developed to investigate the effects of treating young animals and assess potential effects on development.  The guidelines for pharmaceuticals are matched by new regulations for assessing developmental neurotoxicity and thyroid toxicity following exposure to pesticides.

 Who should attend?  The module is intended for management scientists, regulators and study directors, and those with an interest in the pharmaceutical area of drug research. 

Qualifications:   This is a supplementary module of the Modular Training Programme. Credits from eight core modules and one supplementary module from the training programme, together with successful completion of a final examination, can lead to a Postgraduate Diploma in Applied Toxicology. Completion of three additional supplementary modules, or a laboratory or literature based project with satisfactory preparation of a dissertation and, possibly, a viva voce examination, qualifies registered candidates for the award of an MSc in Applied Toxicology. 

The Modular Training Programme in Applied Toxicology has been accredited by the Royal College of Pathologists for the award of Continuing Professional Development credits. 

Course Outline:

 Distance learning material 

Reading Lists and Reprints.  These should be covered before the participant attends the module in order to ensure a familiarity with the topic.

 Lectures, tutorials and discussions

Introduction, history and justification • Legislation: FDA/EPA • Study designs: rodent/non-rodent • Organ system development: critical periods and cross species comparison (CNS, liver, thyroid, kidney, skeletal, cardiovascular, immune system, gastrointestinal tract) • Pharmacokinetics and drug metabolism: comparison of man>animal at stages through development • Industrial perspective • Clinical perspective • Regulator’s approach.

 Case studies on the need, timing, study design and interpretation of juvenile animals studies to enhance lecture content.

Syndicate work will be used to help delegates discuss a number of issues raised. 

Learning objectives:  

 On successful completion of the module, participants should be able to : 

·         understand and appreciate the legislation that is coming into force regarding paediatric medicines;

·         investigate the potential effects of these drugs in juvenile animals compared to the adult animal;

·         investigate the potential effects on development, evaluate species differences and then extrapolate the findings to man. 

Programme speakers:  Lecturers and tutors will be leading authorities from academia, industry, regulatory agencies and private consultancies in the UK and Europe.

 Official course language:  English. 

Assessment:

There will be an optional assessment on the last day of the module.  This will include the pre-course reading material as well as all parts of the module.  Satisfactory performance in this assessment may be accredited towards the total requirement for the MSc/Postgraduate Diploma in Applied Toxicology in accordance with the regulations of the University of Surrey.

 Entrance Requirements and Registration: 

·         Participants who wish to register for the MSc/Postgraduate Diploma should have an academic qualification together with workplace experience in toxicology or a closely related field.  Application to register for a higher award will normally take place following the first or second module attended by a candidate.  Retrospective registration is permitted provided not more than 4 modules have been completed.

·         There are no formal admission requirements for participants not wishing to register for the MSc/Postgraduate Diploma, although a scientific background to at least degree level is recommended.

 Location:  University of Surrey, in Guildford, which is situated adjacent to the A3, on a direct rail link from London, and close to London Heathrow and Gatwick airports (45-60 minutes’ travelling time).

 Accommodation and Meals:  During semester times, hotel or guest house accommodation is available in and around Guildford, while during the University vacations a limited number of rooms will be available on campus. Accommodation costs are not included in the course fees.  Lunches and refreshments will be provided during the course. 

Payment is due on receipt of our invoice which will be sent approximately 8 weeks before the start of the course.  Please see Programme of Modules for current course fees.

 

For further details, please contact the Programme Administrator:-

 

                Telephone: UK+44 (0)1483 689212                                    Fax: UK+44 (0)1483 686401                

Email:  L.Burton@surrey.ac.uk

or visit our web page: http://www.surrey.ac.uk/SBMS/pg_taught_courses/applied-toxicology.htm

               

 

 

 

    

ETS Official Journal: Elsevier Reproductive Toxicology 

click on the icon to directly access the Elsevier Reproduction Toxicology webpage

 

Site information last updated:

12/05/2008

 

you may need to click the refresh button on your browser to view the latest version

    © ETS 1997- 1999, 2001